A recent expert consensus from Chinese authorities presents a comprehensive framework for managing hepatocellular carcinoma (HCC) patients, addressing the complexities posed by chronic liver disease. The 2023 guidelines include 18 recommendations focusing on diagnosis, treatment, and follow-up. These pathways encompass both surgical and nonsurgical strategies, incorporating perioperative care, systematic and local treatment combinations, and tailored interventions for special populations. This initiative aims to improve long-term outcomes and resource management for HCC patients in China.
Review by Yang Y, Sun J (…) Li Q et 67 al. in Liver Cancer
© 2024 The Author(s). Published by S. Karger AG, Basel.